Options for pharmacotherapy and immunotherapy

Postgraduate Medicine

Volumn 101, Issue 5, 1997, Pages 117-131

  Ferguson, Berrylin J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTAZOLINE; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE MALEATE; CLEMASTINE FUMARATE; CROMOGLYCATE DISODIUM; DIPHENHYDRAMINE; FEXOFENADINE; KETOROLAC TROMETAMOL; LEVOCABASTINE; LORATADINE; NAPHAZOLINE; TERFENADINE; UNCLASSIFIED DRUG; VASOCON A; CORTICOSTEROID; DECONGESTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

ALLERGIC RHINITIS; CLOSED ANGLE GLAUCOMA; CONSTIPATION; DROWSINESS; DRUG COST; DRY EYE; HUMAN; IMPOTENCE; REVIEW; URINE RETENTION; DRUG CONTRAINDICATION; DRUG INTERACTION; IMMUNOTHERAPY; PERENNIAL RHINITIS;

ADRENAL CORTEX HORMONES; DRUG INTERACTIONS; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOTHERAPY; NASAL DECONGESTANTS; RHINITIS, ALLERGIC, PERENNIAL;

EID: 0031136966     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1997.05.242     Document Type: Review

References (15)

1. Meltzer EO. An overview of current pharmacotherapy in perennial rhinitis. J Allergy Clin Immunol 1995;95(5 Pt 2):1097-110
2. Safety of terfenadine and astemizole. Med Lett Drugs Ther 1992;34(863):9-10
3. Thompson D, Oster G. Use of terfenadine and contraindicated drugs. JAMA 1996;275(17):1339-41
4. Charesworth EN, Kagey-Sobotka A, Norman PS, et al. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction. J Allergy Clin Immunol 1983;83:905-12
5. Rampe D, Wible B, Brown AM, et al. Effects of terfenadine and its metabolites on a delayed rectifier K+ channel cloned from human heart. Mol Pharmacol 1993;44(6):1240-5
6. Brooks CD, Francom SF, Peel BG, et al. Spectrum of seasonal allergic rhinitis symptom relief with topical corticoid and oral antihistamine given singly or in combination. Am J Rhinol 1996;10:193-9
7. Opatowsky I, Feldman RM, Gross R, et al. Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology 1995;102(2):177-9
8. Fraunfelder FT, Meyer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Ophthalmol 1989;109:489-90
9. Abzug MJ, Cotton MF. Severe chickenpox after intranasal use of corticosteroids. J Pediatr 1993;123(4):577-9
10. Soderberg-Warner ML. Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 1984;105(5): 840-1
11. Mabry RL. Corticosteroids in rhinology. Otolaryngol Head Neck Surg 1995; 108:768-70
12. American Medical Association. Drugs used to treat upper respiratory tract disorders. AMA Drug Evaluations Annual 1992, chap 20, pp 429-57
13. Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol 1995;95(5 Pt 2):1117-22
14. Gordon BR. Immunotherapy basics. Otolaryngol Head Neck Surg 1995;113(5): 597-602
15. American Academy of Otolaryngic Allergy Committee on Practice Standards. Allergic rhinitis: clinical practice guideline. Otolaryngol Head Neck Surg 1996;115(1):115-22